Empirical Finance, LLC’s Eli Lilly & Co Position
Does Empirical Finance, LLC own Eli Lilly & Co (LLY)? Yes — 26.6K shares worth $24M (+1.15% of its 13F portfolio) as of Q1 2026, down from 26.7K shares the prior filed quarter.
Position Value
$24M
Q1 2026
Shares
26.6K
% of Portfolio
+1.15%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 26.6K | $24M | +1.15% |
| Q4 2025 | 26.7K | $29M | +1.37% |
| Q3 2025 | 28.1K | $21M | +1.02% |
| Q2 2025 | 27.7K | $22M | +1.13% |
| Q1 2025 | 27.5K | $23M | +1.37% |
| Q4 2024 | 27.2K | $21M | +1.21% |
| Q3 2024 | 27.5K | $24M | +1.42% |
| Q2 2024 | 26.9K | $24M | +1.52% |
| Q1 2024 | 28.7K | $22M | +1.37% |
| Q4 2023 | 27.7K | $16M | +1.13% |
| Q3 2023 | 27.5K | $15M | +1.09% |
| Q2 2023 | 24.9K | $12M | +0.90% |
| Q1 2023 | 22.1K | $8M | +0.71% |
| Q4 2022 | 21.0K | $8M | +0.80% |
| Q3 2022 | 19.5K | $6M | +0.75% |
| Q2 2022 | 16.4K | $5M | +0.68% |
| Q1 2022 | 15.5K | $4M | +0.50% |
| Q4 2021 | 14.0K | $4M | +0.46% |
| Q3 2021 | 10.3K | $2M | +0.36% |
| Q2 2021 | 18.4K | $4M | +0.31% |
| Q1 2021 | 8.6K | $1M | +0.26% |
| Q4 2020 | 8.6K | $1M | +0.26% |
| Q3 2020 | 7.3K | $1M | +0.23% |
| Q2 2020 | 6.8K | $2M | +0.26% |
| Q1 2020 | 5.1K | $713,000 | +0.22% |
| Q4 2019 | 3.4K | $448,000 | +0.11% |
| Q3 2019 | 2.2K | $251,000 | +0.07% |
| Q2 2019 | 2.2K | $244,000 | +0.07% |
| Q1 2019 | 2.2K | $292,000 | +0.07% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Empirical Finance, LLC’s full portfolio or all institutional holders of LLY.